Bath Savings Trust Co Sells 410 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bath Savings Trust Co lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,212 shares of the medical equipment provider’s stock after selling 410 shares during the quarter. Bath Savings Trust Co’s holdings in Intuitive Surgical were worth $6,896,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Diversified Trust Co raised its holdings in shares of Intuitive Surgical by 0.6% in the 4th quarter. Diversified Trust Co now owns 4,383 shares of the medical equipment provider’s stock worth $2,288,000 after acquiring an additional 25 shares during the last quarter. Capital Market Strategies LLC raised its stake in Intuitive Surgical by 7.8% in the 4th quarter. Capital Market Strategies LLC now owns 1,237 shares of the medical equipment provider’s stock valued at $646,000 after acquiring an additional 90 shares during the period. Nordea Investment Management AB lifted its stake in shares of Intuitive Surgical by 31.7% during the 4th quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider’s stock valued at $22,632,000 after buying an additional 10,405 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Intuitive Surgical by 10.0% during the fourth quarter. GAMMA Investing LLC now owns 5,597 shares of the medical equipment provider’s stock worth $2,921,000 after acquiring an additional 507 shares in the last quarter. Finally, Versant Capital Management Inc lifted its holdings in Intuitive Surgical by 27.4% during the 4th quarter. Versant Capital Management Inc now owns 688 shares of the medical equipment provider’s stock worth $359,000 after purchasing an additional 148 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $9.42 during trading hours on Tuesday, hitting $532.95. The company had a trading volume of 630,443 shares, compared to its average volume of 1,000,047. Intuitive Surgical, Inc. has a 52-week low of $324.12 and a 52-week high of $556.23. The firm has a fifty day moving average price of $533.39 and a 200-day moving average price of $492.20. The stock has a market capitalization of $189.83 billion, a price-to-earnings ratio of 85.68, a P/E/G ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 in the last quarter. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have commented on ISRG. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James increased their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Finally, Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.